Array
(
[id] => 1341
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1341.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => PCC administration in low doses guided by VHA (prolonged coagulation initiation or increased INR if no VHA available) is suggested in the presence of clinically significant bleeding in patients without fibrinogen deficiency.（Evidence level: low；Recommendation grade:weak）
[laiyuan] => 建议在没有纤维蛋白原缺乏的患者存在临床显著出血的情况下，在粘弹性止血试验指导下低剂量给予凝血酶原复合物浓缩物(如果没有粘弹性止血试验，则延长凝血起始时间或增加INR)。（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议在没有纤维蛋白原缺乏的患者存在临床显著出血的情况下，在粘弹性止血试验指导下低剂量给予凝血酶原复合物浓缩物(如果没有粘弹性止血试验，则延长凝血起始时间或增加INR)。（证据级别：低；推荐强度：弱推荐）
PCC administration in low doses guided by VHA (prolonged coagulation initiation or increased INR if no VHA available) is suggested in the presence of clinically significant bleeding in patients without fibrinogen deficiency.（Evidence level: low；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1342
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1342.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In liver transplant, fibrinogen concentrate use should be restricted only to patients with documented hypofi-brinogenaemia (by standard coagulation tests or VHA). （Evidence level: low；Recommendation grade: strong）
[laiyuan] => 在肝移植中，纤维蛋白原浓缩物的使用应仅限于有低纤维蛋白原血症记录的患者(通过标准凝血试验或VHA)。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在肝移植中，纤维蛋白原浓缩物的使用应仅限于有低纤维蛋白原血症记录的患者(通过标准凝血试验或VHA)。（证据级别：低；推荐强度：强推荐）
In liver transplant, fibrinogen concentrate use should be restricted only to patients with documented hypofi-brinogenaemia (by standard coagulation tests or VHA). （Evidence level: low；Recommendation grade: strong）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1343
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1343.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Preemptive fibrinogen administration before liver transplantation is not recommended. （Evidence level: low；Recommendation grade: strong）
[laiyuan] => 不建议在肝移植前预防性使用纤维蛋白原。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
不建议在肝移植前预防性使用纤维蛋白原。（证据级别：低；推荐强度：强推荐）
Preemptive fibrinogen administration before liver transplantation is not recommended. （Evidence level: low；Recommendation grade: strong）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1344
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1344.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => rFVIIa is not recommended for routine use in OLT and should be used only as rescue therapy for uncontrolled bleeding. （Evidence level: low；Recommendation grade: strong）
[laiyuan] => rFVIIa不推荐常规用于肝移植，仅可用于未控制出血的补救治疗。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
rFVIIa不推荐常规用于肝移植，仅可用于未控制出血的补救治疗。（证据级别：低；推荐强度：强推荐）
rFVIIa is not recommended for routine use in OLT and should be used only as rescue therapy for uncontrolled bleeding. （Evidence level: low；Recommendation grade: strong）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1345
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1345.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest the use of cell salvage and autotransfusion with leukodepletion filters in liver transplantation includ_x005fing patients with HCC. （Evidence level: low；Recommendation grade: weak）
[laiyuan] => 我们建议在肝移植中，包括有HCC的病人，应使用细胞回收和白细胞去除滤器的自体输血。（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议在肝移植中，包括有HCC的病人，应使用细胞回收和白细胞去除滤器的自体输血。（证据级别：低；推荐强度：弱推荐）
We suggest the use of cell salvage and autotransfusion with leukodepletion filters in liver transplantation includ_x005fing patients with HCC. （Evidence level: low；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1346
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1346.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => TXA administered systemically or locally in the irrigant fluid may be considered in order to decrease peri-operative blood loss in percutaneous nephrolithotomy. （Evidence level: moderate；Recommendation grade: weak）
[laiyuan] => 在经皮肾镜取石术中，可以考虑全身或局部灌注XA，以减少围手术期出血量。（证据级别：中；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在经皮肾镜取石术中，可以考虑全身或局部灌注XA，以减少围手术期出血量。（证据级别：中；推荐强度：弱推荐）
TXA administered systemically or locally in the irrigant fluid may be considered in order to decrease peri-operative blood loss in percutaneous nephrolithotomy. （Evidence level: moderate；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1347
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1347.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => TXA may be considered in order to decrease peri-operative blood loss in prostate surgery. （Evidence level: moderate；Recommendation grade: weak）
[laiyuan] => 在前列腺手术中可考虑使用TXA以减少围手术期失血量。（证据级别：中；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在前列腺手术中可考虑使用TXA以减少围手术期失血量。（证据级别：中；推荐强度：弱推荐）
TXA may be considered in order to decrease peri-operative blood loss in prostate surgery. （Evidence level: moderate；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1348
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1348.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Prophylactic administration of fibrinogen concentrate is not recommended in prostate surgery. （Evidence level: low；Recommendation grade:strong）
[laiyuan] => 在前列腺手术中不推荐预防性使用纤维蛋白原浓缩物。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在前列腺手术中不推荐预防性使用纤维蛋白原浓缩物。（证据级别：低；推荐强度：强推荐）
Prophylactic administration of fibrinogen concentrate is not recommended in prostate surgery. （Evidence level: low；Recommendation grade:strong）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1349
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1349.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Computed tomography scan or angiography are suggested for the diagnosis of late bleeding after pancreatectomy, and endovascular interventional therapy is suggested as primary treatment. （Evidence level: low；Recommendation grade:weak）
[laiyuan] => 胰腺切除术后迟发性出血的诊断建议行CT或血管造影检查，血管内介入治疗为首选治疗方法。（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
胰腺切除术后迟发性出血的诊断建议行CT或血管造影检查，血管内介入治疗为首选治疗方法。（证据级别：低；推荐强度：弱推荐）
Computed tomography scan or angiography are suggested for the diagnosis of late bleeding after pancreatectomy, and endovascular interventional therapy is suggested as primary treatment. （Evidence level: low；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1350
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1350.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Preoperative chronic antithrombotic therapy and perioperative chemical thromboprophylaxis seem not to increase the peri-operative haemorrhagic complications in patients undergoing HPB surgery. （Evidence level: low）
[laiyuan] => 术前长期抗栓治疗和围手术期预防性化学血栓治疗不会增加HPB患者围手术期出血并发症的发生。（证据级别：低）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
术前长期抗栓治疗和围手术期预防性化学血栓治疗不会增加HPB患者围手术期出血并发症的发生。（证据级别：低）
Preoperative chronic antithrombotic therapy and perioperative chemical thromboprophylaxis seem not to increase the peri-operative haemorrhagic complications in patients undergoing HPB surgery. （Evidence level: low）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
